News and Stories About clinical trials
Experts Discuss Adaptive Platform Clinical Trials
Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE
7 Questions to Ask About Pancreatic Cancer Treatment
When talking to your doctor about pancreatic cancer treatment, it can be hard to know what questions to ask. Developing […]
READ MORE
What Is Cancer Immunotherapy?
Editor’s note: In honor of June being Cancer Immunotherapy Month, we’re sharing information about this treatment approach and how it […]
READ MORE
5 Things to Know About Precision Medicine
Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE
Positive Clinical Trial Results Presented at Major Oncology Conference
This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE
‘Bench to Bedside’ Project Shows Promise in Pancreatic Cancer Patients
A new treatment combination – combining chemotherapy and radiation therapy with a common blood pressure drug – has shown promise […]
READ MORE
PNET Survivor Receives ‘Gift’ Through Molecular Profiling
The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE
Years Later, Stage IV Survivor Continues Mission to Spread Hope and Create Memories
The name Earl Groce may sound familiar to you. In January 2018, the then two-and-a-half-year survivor lent his voice during […]
READ MORE
Research Shows Racial Inequalities in Cancer Care
Editor’s Note: In honor of National Minority Health Month, we would like to shed some light on the issues of […]
READ MORE
PanCAN Discusses Partnerships that Support Patients
On April 3, the Pancreatic Cancer Action Network’s (PanCAN) associate director of clinical initiatives, Cassadie Moravek, joined other patient advocacy […]
READ MORE
What a Researcher Learned Developing a New Drug for Pancreatic Cancer
Editor’s note: In this Washington Post article, Nathaniel Brooks Horwitz wrote about his experience launching biopharmaceutical company Nivien Therapeutics in […]
READ MORE
Pancreatic Cancer Treatment in the News
“There is no way to sugarcoat the fact that pancreatic cancer is very difficult to treat,” begins an article recently […]
READ MORE
Recognizing African-American History Month
It’s African-American History Month, which pays tribute to generations of African-Americans who struggled with adversity to achieve full citizenship in […]
READ MORE
How to Spot Fake Science News
Do you ever see scientific or medical headlines that sound too good to be true? Ask these questions to help […]
READ MORE
Shedding Light on Clinical Trials: Safety
The Pancreatic Cancer Action Network’s Patient Central Associates hear many questions and concerns from patients and caregivers about clinical trial […]
READ MORE
3 Posters, 1 Major Conference
A large group of Pancreatic Cancer Action Network (PanCAN) leadership and Scientific and Medical Affairs staff are attending the 2019 […]
READ MORE
African Americans at Increased Risk for Pancreatic Cancer
U.S. Representative Alcee Hastings (D-Fla.) announced this week that he is undergoing treatment for pancreatic cancer. The diagnosis is a […]
READ MORE
Shedding Light on Clinical Trials: Eligibility Criteria
Clinical trials are developed to answer certain research questions. To get the right information to answer those questions, a trial […]
READ MORE
Shedding Light on Clinical Trials: An Overview
Editor’s Note: Because this week is Clinical Trials Awareness Week, we wanted to provide an overview of what the clinical […]
READ MORE
A Deeper Look at Clinical Trials
January is National Pancreatic Cancer Clinical Trials Awareness Month. Pancreatic cancer patients who participate in clinical research have better outcomes. […]
READ MORE
2018 Year in Review: Top 10 Pancreatic Cancer News Stories
Editor’s note: Today’s edition of the 2018 Year in Review series features the 10 most popular news stories on the […]
READ MORE
2018 Year in Review: Progress in Research, Part 1
Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE
I Demand Better: Michael Curran, PhD
Editor’s note: Michael Curran, PhD, is a 2018 Pancreatic Cancer Action Network (PanCAN) Translational Research Grant recipient. He is an […]
READ MORE
‘Contacting PanCAN Was the Best Thing I Did’
After more than a year and a half of abdominal pain and digestive issues, Gail Bamer was diagnosed with stage […]
READ MORE
Pancreatic Cancer Clinical Trials in the United States Today
Did you know there are more than 180 different pancreatic cancer clinical trials currently enrolling patients in the United States? […]
READ MORE
Clinical Trials 101
It’s that time of year again – back-to-school season. In keeping with the theme, we’re sharing a basic overview of […]
READ MORE
Read How Allison Got on the Right Track
Editor’s note: Allison Lippman got on the Right Track. Learn more. Before Allison Lippman of Dallas met her now-husband, she […]
READ MORE
Pancreatic Cancer Treatment Myths Uncovered
It is important to know all your treatment options at every stage of your pancreatic cancer diagnosis. Here are five […]
READ MORE
What to Know About Groundbreaking New FOLFIRINOX Clinical Trial Results
Editor’s note: You may have heard breakthrough news that came out of the American Society of Clinical Oncology (ASCO) Annual […]
READ MORE
Breakthrough: Studies Show Benefit of Treatments Before and After Surgery
On day four of the American Society of Clinical Oncology (ASCO) Annual Meeting, results of two critically important phase III […]
READ MORE
La Participación de Pacientes Latinos y Afroamericanos Es Crucial para Nuevas Opciones de Tratamiento
Editor’s note: April is National Minority Health Month. This blog, entitled “Diverse Patient Participation Crucial for New Treatment Options,” has […]
READ MORE
National Doctors’ Day: Honoring Roles and Importance of Specialists
Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE
Survivor Advocates for a Second Opinion
In June 2014, David Wingo went to his doctor about abdominal pain. While investigating the pain, his doctor noticed a […]
READ MORE
6 Reasons Why Clinical Trials Are Safe
Editor’s note: In honor of personalized search. To take that personalization a step further, pancreatic cancer patients can undergo molecular […]
READ MORE
Precision Medicine Highlighted in the News
“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE
Precision Promise Spotlighted at International Conference
The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE
Innovation in Action: Precision Promise Update
The Pancreatic Cancer Action Network (PanCAN) is excited to launch Precision PromiseSM in 2019. Precision Promise is the first adaptive […]
READ MORE
5 Key Facts about PNETs
What exactly are pancreatic neuroendocrine tumors (PNETs), and how do they differ from other types of pancreatic cancer? Here are […]
READ MORE
Lutathera® Drug Approved for Pancreatic Neuroendocrine Tumors
Today, the U.S. Food & Drug Administration (FDA) approved Lutathera® (lutetium-177 (177Lu)-Dotatate) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), […]
READ MORE
Clinical Trial Participant Encourages Patients to Actively Seek Clinical Trials
In September 2015, Earl Groce returned home to North Carolina after driving 5,500 miles cross-country for his first trip to […]
READ MORE
Diverse Patient Participation Crucial for New Treatment Options
Editor’s note: It’s National Diversity Day, and as such, we are republishing this article about the importance of diversity in […]
READ MORE
Clinical Trials Awareness Month 2018
The Pancreatic Cancer Action Network Urges All Pancreatic Cancer Patients to Consider Clinical Trial Enrollment Pancreatic Cancer Patients Who Participate […]
READ MORE
9-Year Survivor Says Clinical Trials Saved His Life
Richard Blish, a nine-year pancreatic cancer survivor, was diagnosed in 2009 with a marginally resectable tumor and less than a […]
READ MORE
The Critical Role of Patients in Clinical Trials
This year during National Pancreatic Cancer Clinical Trials Awareness Month, we Demand Better. For Patients. For Survival. Matt Wilson, a […]
READ MORE
Help Raise Awareness for Clinical Trials
January is National Pancreatic Cancer Clinical Trials Awareness Month. Thanks to the community’s participation last year, the Pancreatic Cancer Action […]
READ MORE
Keytruda Drug Is Science Breakthrough of the Year Runner-up
At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE
Finding the Right Clinical Trial for You
Choosing a clinical trial on your own can be challenging. Some trial listings are out-of-date, and others require looking through […]
READ MORE
Survey Highlights the Importance of Seeing Specialists
Published in the Journal of Gastrointestinal Cancer, a recent survey of 150 oncologists showed a lack of compliance with evidence-based […]
READ MORE
Going Beyond Standard of Care
Pancreatic cancer is difficult to treat. There are a few standard treatments, but there are additional options that we encourage […]
READ MORE
Cancer Drugs in the News
An article published yesterday in Newsweek describes a European analysis that found cancer drugs are being approved without adequate evidence […]
READ MORE
10 Tips to Help You Get Organized After Diagnosis
A pancreatic cancer diagnosis and the decisions that come after can feel overwhelming. But getting organized can help patients and […]
READ MORE
Hispanics Losing Opportunities to Access Leading-Edge Treatments for Pancreatic Cancer
A news article originally published in USA Today explored the relatively low number of Hispanics who enroll in clinical trials […]
READ MORE
Forbes Article Discusses Potential of PARP Inhibitors to Treat Certain Pancreatic Cancer Patients
The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE
Discovery Channel Clinical Trials Series: Episode 3 – “Prognosis”
The final episode of a three-part documentary, First in Human, aired on Aug. 24, on Discovery. The six-hour series provided a […]
READ MORE
Discovery Channel Clinical Trials Series: Episode 2 – “Treatment”
The second episode of the three-part Discovery documentary on clinical trials, First in Human, follows the gripping story of three […]
READ MORE
Discovery Channel Takes In-Depth Look into Experimental Clinical Trials
The first episode of a three-part documentary, First in Human, debuted Aug. 10, on Discovery. The six-hour series provides a […]
READ MORE
Report Shows Clinical Trial Misconceptions Prevail
Clinical trials are critical to advance treatment options, and pancreatic cancer patients who participate in clinical research have better outcomes. […]
READ MORE
5 Things to Know About New Drug Keytruda
Editor’s note: Keytruda was the first cancer drug approved to treat any solid tumor – anywhere in the body – […]
READ MORE
Racial Disparities Exist in Cancer Care, Research Shows
In 2009, Jennifer Tseng, MD, and her team were scouring a National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End results […]
READ MORE
“Beyond Cancer” Examines Clinical Trials, Early Detection, Immunotherapy and Other Cancer Advances
CBS “Sunday Morning” aired a special titled, “Beyond Cancer,” featuring the latest news on research, diagnosis and treatments, plus stories […]
READ MORE
Meet Dr. Vince Picozzi, Chair of the Precision Promise Clinical Trial Consortium
Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE
Pancreatic Cancer Expert Calls for More Awareness for the Disease and Clinical Trials
The online healthcare publisher OncLive often features interviews with doctors and researchers who specialize in pancreatic cancer. This week they […]
READ MORE
Patient Central Is Here To Help You With Clinical Trials Information
Throughout National Pancreatic Cancer Clinical Trials Awareness Month, you’ve received a lot of information. We’ve shared firsthand survivor stories, provided […]
READ MORE
10 Questions to Ask About Clinical Trials
Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical […]
READ MORE
Clinical Trials Are Recommended During Every Treatment Decision
Making treatment decisions may be overwhelming. We want to make sure you have the information you need, every step of […]
READ MORE
5 Cancer Clinical Trial Myths Debunked
Facts by an MD, backed by cancer survivors We spoke with Victoria Manax Rutson, MD, the chief medical officer for […]
READ MORE
January is National Pancreatic Cancer Trials Awareness Month
Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical […]
READ MORE
What Are Some Alternatives to Standard Treatment?
It can be difficult to keep track of the different treatment options available for pancreatic cancer, and many patients are […]
READ MORE
Clinical Trial Finder Takes Home the Bronze
Olympians aren’t the only people taking home medals. We are proud to have won bronze for our Clinical Trial Finder […]
READ MORE
Joining Forces with Let’s Win!, an Initiative of The Lustgarten Foundation
Fighting pancreatic cancer is no easy task. That’s why the Pancreatic Cancer Action Network is excited to join forces with […]
READ MORE
New Study of Pancreatic Cancer Clinical Trials Reveals Opportunities for the Future
A rigorous analysis of 25 years’ worth of pancreatic cancer clinical trial data was published on June 6, 2016, in […]
READ MORE
Grantee’s Early-Phase Immunotherapy Clinical Trial Shows Encouraging Results
Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.
Pancreatic Cancer Patients Encouraged to Consider Clinical Trial Enrollment
Pancreatic Cancer Patients Encouraged to Consider Clinical Trial Enrollment MANHATTAN BEACH, Calif. – (January 6, 2016) — With no effective screening […]
READ MORE
